Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Haematology
|
July 13, 2025
Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study
Freja Tang Severinsen, Mikkel Runason Simonsen, Eva Futtrup Maksten, et al.
Future Oncology (London, England)
|
June 22, 2021
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system
Rasmus F Brøndum, Anne S Vestergaard, Lars Børty, et al.
Leukemia & Lymphoma
|
October 14, 2016
R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients
Pernille Svendsen, Nitesh Shekhrajka, Kasper Lindblad Nielsen, et al.
American Journal of Hematology
|
February 5, 2014
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma
T C El-Galaly, Karen Juul Mylam, Martin Bøgsted, et al.
European Journal of Haematology
|
January 9, 2025
Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting
Tine Litske Bennedsen, Mikkel Runason Simonsen, Paw Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2017
Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study
Lasse Hjort Jakobsen, Martin Bøgsted, Peter de Nully Brown, et al.
Leukemia & Lymphoma
|
February 12, 2020
Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study
Joachim Baech, Steen Moeller Hansen, Lasse Hjort Jakobsen, et al.
Cancers
|
February 5, 2020
Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
Julie S Bødker, Mads Sønderkær, Charles Vesteghem, et al.
Leukemia & Lymphoma
|
September 3, 2024
The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study
Mikkel Runason Simonsen, Laura Mors Haunstrup, Freja Tang Severinsen, et al.
Leukemia & Lymphoma
|
October 21, 2014
(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
Karen Juul Mylam, Lale Kostakoglu, Martin Hutchings, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Haematology
|
July 13, 2025
Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study
Freja Tang Severinsen, Mikkel Runason Simonsen, Eva Futtrup Maksten, et al.
Future Oncology (London, England)
|
June 22, 2021
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system
Rasmus F Brøndum, Anne S Vestergaard, Lars Børty, et al.
Leukemia & Lymphoma
|
October 14, 2016
R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients
Pernille Svendsen, Nitesh Shekhrajka, Kasper Lindblad Nielsen, et al.
American Journal of Hematology
|
February 5, 2014
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma
T C El-Galaly, Karen Juul Mylam, Martin Bøgsted, et al.
European Journal of Haematology
|
January 9, 2025
Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting
Tine Litske Bennedsen, Mikkel Runason Simonsen, Paw Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2017
Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study
Lasse Hjort Jakobsen, Martin Bøgsted, Peter de Nully Brown, et al.
Leukemia & Lymphoma
|
February 12, 2020
Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study
Joachim Baech, Steen Moeller Hansen, Lasse Hjort Jakobsen, et al.
Cancers
|
February 5, 2020
Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
Julie S Bødker, Mads Sønderkær, Charles Vesteghem, et al.
Leukemia & Lymphoma
|
September 3, 2024
The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study
Mikkel Runason Simonsen, Laura Mors Haunstrup, Freja Tang Severinsen, et al.
Leukemia & Lymphoma
|
October 21, 2014
(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
Karen Juul Mylam, Lale Kostakoglu, Martin Hutchings, et al.
Page
of 4